Scouted selects products independently. If you purchase something from our posts, we may earn a small commission.
If you frequent a cosmetic dermatologist for regularly scheduled neurotoxin wrinkle relaxers (Botox, Dysport, etc.), the odds are high that you’ve already heard about Sculptra from your derm or aesthetic injector. Sculptra (poly-L-lactic acid) is an injectable bio-stimulatory dermal filler touted for gradually addressing volume loss and yielding more natural results than hyaluronic acid-based fillers like Juvederm and Restylane. Sculptra was approved by the FDA for addressing facial fat loss back in 2004 (primarily for those suffering from HIV and AIDS-induced facial lipoatrophy), but over two decades later, the collagen-and-elastin-boosting injectable treatment is surging in popularity seemingly all of a sudden.
According to Alan Widgerow, Chief Scientific Officer at Galderma (the pharmaceutical company behind Sculptra and other dermatological treatments), this is partly due to continued research and the discovery of new benefits. “25 years since the first approval of Sculptra, we are delighted to still be delving deeper into its science and uncovering new properties,” he says. “We’ve now seen that Sculptra stimulates the three layers of the skin, making it the first proven regenerative biostimulator. This opens up new possibilities [for] Sculptra to address emerging aesthetic needs such as facial alterations associated with rapid weight loss.”
Read more at The Daily Beast.
